David Andorsky

Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes

David Andorsky, Dennis P. Lund, C. Walton Lillehei et al. · The Journal of Pediatrics · 2001 · 450 citations

Medicine, Nutrition, Nutritional Sciences +16

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

Philippe Armand, Arnon Nagler, Edie Weller et al. · Journal of Clinical Oncology · 2013 · 439 citations · Full text

Medicine, Hematology, Oncology +17

Programmed Death Ligand 1 Is Expressed by Non–Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells

David Andorsky, Reiko Yamada, Jonathan Said et al. · Clinical Cancer Research · 2011 · 326 citations · Full text

Life Sciences, Immunology, Oncology +17

Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial

Jeffrey H. Lipton, Charles Chuah, Agnès Guerci‐Bresler et al. · The Lancet Oncology · 2016 · 259 citations

Medicine, Hematology, Pharmacology +6

Asciminib in Newly Diagnosed Chronic Myeloid Leukemia

Andreas Hochhaus, Jianxiang Wang, Dong‐Wook Kim et al. · New England Journal of Medicine · 2024 · 139 citations

Medicine, Oncology, Pharmacology +8